Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,187 | 835 | 98.9% |
| Education | $130.09 | 4 | 1.0% |
| Gift | $11.50 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,418 | 80 | $0 (2024) |
| Novo Nordisk Inc | $1,022 | 54 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $999.93 | 62 | $0 (2024) |
| ABBVIE INC. | $944.03 | 52 | $0 (2024) |
| Lilly USA, LLC | $903.20 | 64 | $0 (2024) |
| PFIZER INC. | $851.04 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $713.44 | 51 | $0 (2024) |
| Merck Sharp & Dohme LLC | $701.71 | 57 | $0 (2023) |
| Amgen Inc. | $651.00 | 36 | $0 (2024) |
| Allergan, Inc. | $541.00 | 35 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,027 | 49 | AstraZeneca Pharmaceuticals LP ($140.03) |
| 2023 | $1,838 | 91 | AbbVie Inc. ($293.97) |
| 2022 | $1,455 | 85 | ABBVIE INC. ($293.22) |
| 2021 | $1,930 | 115 | AbbVie Inc. ($281.78) |
| 2020 | $1,323 | 79 | AstraZeneca Pharmaceuticals LP ($238.51) |
| 2019 | $1,740 | 114 | AstraZeneca Pharmaceuticals LP ($250.83) |
| 2018 | $1,829 | 139 | Merck Sharp & Dohme Corporation ($196.21) |
| 2017 | $2,186 | 168 | Allergan Inc. ($322.08) |
All Payment Transactions
840 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $29.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.33 | General |
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Gastroenterology | ||||||
| 06/14/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.29 | General |
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Central Nervous System | ||||||
| 05/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 05/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.62 | General |
| 05/11/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 04/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Central Nervous System | ||||||
| 04/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 75 | 89 | $13,567 | $5,285 |
| 2022 | 1 | 23 | 32 | $6,400 | $2,031 |
| 2021 | 1 | 17 | 22 | $4,400 | $1,512 |
| 2020 | 1 | 11 | 12 | $2,148 | $903.74 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 37 | $7,670 | $2,595 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 23 | $3,397 | $1,330 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 15 | $1,800 | $924.92 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $700.00 | $434.56 | 62.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 32 | $6,400 | $2,031 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 22 | $4,400 | $1,512 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $2,148 | $903.74 | 42.1% |
About Dr. James Weingart, MD
Dr. James Weingart, MD is a Family Medicine healthcare provider based in Thornton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679529440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Weingart, MD has received a total of $13,329 in payments from pharmaceutical and medical device companies, with $1,027 received in 2024. These payments were reported across 840 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($13,187).
As a Medicare-enrolled provider, Weingart has provided services to 126 Medicare beneficiaries, totaling 155 services with total Medicare billing of $9,732. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Thornton, CO
- Active Since 05/25/2006
- Last Updated 10/14/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1679529440
Products in Payments
- VRAYLAR (Drug) $828.91
- FARXIGA (Drug) $660.05
- JARDIANCE (Drug) $567.04
- Ozempic (Drug) $524.60
- ELIQUIS (Drug) $402.28
- JANUVIA (Drug) $369.05
- SYMBICORT (Drug) $352.64
- XARELTO (Drug) $336.83
- STIOLTO RESPIMAT (Drug) $324.99
- TRELEGY ELLIPTA (Drug) $306.56
- CHANTIX (Drug) $305.04
- TRULICITY (Drug) $284.85
- LINZESS (Drug) $252.65
- UBRELVY (Drug) $240.87
- EMGALITY (Drug) $233.98
- MOUNJARO (Drug) $230.93
- MYRBETRIQ (Drug) $229.29
- ANORO (Drug) $212.16
- TOUJEO (Drug) $193.44
- Aimovig (Biological) $191.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Thornton
Dr. Kenneth Hahn, Do, DO
Family Medicine — Payments: $21,946
Dr. Philip Rosenblum, Md, MD
Family Medicine — Payments: $19,181
Kent Schreiber, Md, MD
Family Medicine — Payments: $18,397
Dr. Suzanne Nash, Md, MD
Family Medicine — Payments: $16,812
Ann Imhof, Md, MD
Family Medicine — Payments: $12,668
Nancy Stoudt, Md, MD
Family Medicine — Payments: $10,008